Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 64,046 shares at $18.28 ($1.2M) on 2024-11-13, disclosed to the SEC on 2024-11-15.
Scheduled sale ($1.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.28 | 32,023 | $585K | 50.0% |
| 2 | $18.28 | 32,023 | $585K | 50.0% |
| Total | $18.28 avg | 64,046 | $1.2M | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |